Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLY-BIRD ACS Trial
NCT07824323Phase 4Recruiting
- Sponsor
- Taipei Medical University Hospital
- Start
- Aug 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Phase 4 trial of bempedoic acid in acute coronary syndrome (ACS) and dyslipidemia, sponsored by Taipei Medical University Hospital. Started Aug 2026; status: recruiting.
02
Drugs
bempedoic acid
03
Conditions
acute coronary syndrome (ACS)dyslipidemia
Beyond the preview
Go deeper on NCT07824323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07824323.